Press Release
FOR IMMEDIATE RELEASE:
February 2, 2026
CONTACT:
Kathleen Reichert
American Skin Association
917-538-5731
Kathleen@americanskin.org
AMERICAN SKIN ASSOCIATION ANNOUNCES APPOINTMENT OF PATRICK M. BRUNNER, MD, MSc TO MEDICAL ADVISORY COMMITTEE
Internationally recognized clinician scientist and skin immunology expert joins ASA to advance research and patient care
February 2, 2026, New York, NY – American Skin Association (ASA) is pleased to announce the appointment of Patrick M. Brunner, MD, MSc, to its Medical Advisory Committee (MAC). A board-certified dermatologist and clinician scientist whose work in skin immunology and inflammatory skin disease has helped shape clinical understanding of atopic dermatitis and related dermatologic conditions.
Dr. Brunner serves as Associate Professor of Dermatology and Director of the Cutaneous Lymphoma Clinic at the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai. His research connects sophisticated immunologic methods with real-world clinical care, helping translate scientific discoveries into more effective practical tools for patients.
"Dr. Brunner is an exceptional addition to ASA's Medical Advisory Committee," said Howard P. Milstein, Chairman of ASA. "His vast scientific insight, combined with a drive to improve outcomes for patients as a complex, inflammatory, and patient-centered approach ASA seeks to champion."
Dr. Patrick Brunner earned his medical degree from the Medical University of Vienna. He then finished his residency in Dermatology at the Department of Dermatology at the Medical University of Vienna. Seeking to merge his clinical interests with laboratory-based biomedical investigation in New York, There, he pursued advanced training in clinical and translational dermatology and conducted seminal research in atopic dermatitis under the mentorship of Board members, Drs. Emma Guttman-Yassky and James G. Krueger, Brunner then returned to the Medical University of Vienna as faculty and and led an independent research group dedicated to clinical investigation in chronic inflammatory skin disease and primary cutaneous lymphomas. Dr. Brunner made the move back to New York as Assistant Professor of Medicine and then Associate Professor, all at the Icahn School of Medicine at Mount Sinai in NYC.
"Patrick Brunner, MD, combines deep scientific insight, practical research, and outstanding clinical expertise," said James G. Krueger, MD, PhD, President of ASA. "His work will help us expand our understanding of how immune pathways drive skin disease, and his perspective will be invaluable for ASA and our work."
Dr. Brunner's clinical and research efforts focus on various immune-mediated skin disorders, with a focus on cutaneous lymphomas, atopic dermatitis, and vitiligo. In vitiligo specifically, his ongoing efforts focus on improving tissue-based sampling techniques and defining the biological features that contribute to disease severity, progression, treatment resistance and treatment resistance.
ABOUT AMERICAN SKIN ASSOCIATION
A unique collaboration of patients, families, advocates, physicians, and scientists, ASA has evolved over nearly four decades as a leading force in efforts to defeat melanoma, vitiligo, psoriasis, atopic dermatitis, and other skin diseases. Established to serve the now more than 100 million Americans — one-third of the U.S. population — afflicted with skin disorders, the organization's mission remains to: advance research, champion skin health, particularly among children, and drive public awareness about skin disease. ASA is a 501(c)3 nonprofit organization. For more information, visit americanskin.org.
American Skin Association has earned Candid's 2026 Seal of Platinum Transparency and the Four-Star Rating from Charity Navigator.
